MAGNESIUM SULFATE (HEPTAHYDRATE)

MAGNESIUM SULFATE (HEPTAHYDRATE) was reported 13182 times

MAGNESIUM SULFATE (HEPTAHYDRATE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SCHIZENCEPHALY 9 0.2000
1 CEREBRAL HAEMORRHAGE FOETAL 9 0.1475
2 ANTITHROMBIN III DEFICIENCY 1 0.0112
3 BONE FORMATION DECREASED 1 0.0063
4 BLOOD MAGNESIUM INCREASED 5 0.0055
5 SOMNOLENCE NEONATAL 1 0.0051
6 XERODERMA 1 0.0037
7 HUMAN HERPESVIRUS 6 ENCEPHALITIS 1 0.0035
8 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
9 VITAMIN B1 DEFICIENCY 1 0.0023
10 METASTASES TO KIDNEY 1 0.0018
11 OSTEOGENESIS IMPERFECTA 1 0.0017
12 PALATAL DISORDER 1 0.0017
13 HYPERMAGNESAEMIA 1 0.0015
14 FOETAL HEART RATE DECELERATION ABNORMALITY 1 0.0014
15 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
16 RESPIRATORY ALKALOSIS 2 0.0012
17 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
18 PULMONARY INFARCTION 2 0.0008
19 RECTAL PROLAPSE 1 0.0008
20 NECROTISING COLITIS 1 0.0008
21 ABORTION INDUCED 7 0.0007
22 ECHOCARDIOGRAM ABNORMAL 1 0.0007
23 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
24 RESPIRATORY FAILURE 45 0.0006
25 LIP DISORDER 1 0.0005
26 ANORECTAL DISORDER 1 0.0005
27 DERMAL CYST 1 0.0004
28 DERMATITIS ACNEIFORM 2 0.0003
29 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
30 OLIGOHYDRAMNIOS 1 0.0003
31 METASTASES TO SPINE 1 0.0003
32 CONJUNCTIVAL HYPERAEMIA 1 0.0003
33 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
34 TORSADE DE POINTES 2 0.0003
35 EXPOSURE VIA BREAST MILK 1 0.0003
36 HYPERURICAEMIA 1 0.0002
37 GASTROINTESTINAL PERFORATION 1 0.0002
38 PARONYCHIA 1 0.0002
39 BRONCHOSPASM 3 0.0002
40 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
41 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
42 SKIN NECROSIS 1 0.0002
43 SKIN LACERATION 2 0.0002
44 CHOLECYSTITIS ACUTE 1 0.0002
45 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
46 COVID-19 PNEUMONIA 2 0.0002
47 INFUSION SITE PAIN 2 0.0002
48 SARS-COV-2 TEST POSITIVE 2 0.0002
49 CONDITION AGGRAVATED 45 0.0001
50 ACUTE HEPATIC FAILURE 2 0.0001
51 HYPOMAGNESAEMIA 2 0.0001
52 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
53 ACIDOSIS 1 0.0001
54 LACTIC ACIDOSIS 4 0.0001
55 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
56 POST PROCEDURAL INFECTION 1 0.0001
57 HICCUPS 1 0.0001
58 NAIL DISORDER 1 0.0001
59 EXPOSURE DURING PREGNANCY 7 0.0001
60 DIZZINESS POSTURAL 1 0.0001
61 TOOTH ABSCESS 1 0.0001
62 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
63 VENTRICULAR EXTRASYSTOLES 1 0.0001
64 VENTRICULAR FIBRILLATION 1 0.0001
65 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
66 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
67 HYPERGLYCAEMIA 3 0.0001
68 INJECTION SITE EXTRAVASATION 1 0.0001
69 UNRESPONSIVE TO STIMULI 2 0.0001
70 ORAL CANDIDIASIS 1 0.0001
71 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
72 HEPATIC FAILURE 2 0.0001
73 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
74 DEVICE RELATED INFECTION 1 0.0001
75 PNEUMOTHORAX 1 0.0001
76 VENTRICULAR TACHYCARDIA 1 0.0001
77 ORTHOSTATIC HYPOTENSION 1 0.0001
78 METASTASES TO LIVER 1 0.0001
79 HYPOXIA 2 0.0001
80 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
81 MEDICATION ERROR 3 0.0001
82 HYPOCALCAEMIA 1 0.0001
83 FEEDING DISORDER 1 0.0000
84 TASTE DISORDER 1 0.0000
85 NEUTROPHIL COUNT DECREASED 2 0.0000
86 BODY TEMPERATURE INCREASED 1 0.0000
87 PRURITUS GENERALISED 1 0.0000
88 INFUSION RELATED REACTION 3 0.0000
89 FEBRILE NEUTROPENIA 3 0.0000
90 TACHYCARDIA 4 0.0000
91 HYPOKALAEMIA 2 0.0000
92 HYPOGLYCAEMIA 2 0.0000
93 INJECTION SITE URTICARIA 1 0.0000
94 HYPOTENSION 8 0.0000
95 RESPIRATORY DISTRESS 1 0.0000
96 NECK PAIN 2 0.0000
97 TOXICITY TO VARIOUS AGENTS 6 0.0000
98 HYPONATRAEMIA 2 0.0000
99 FEELING HOT 2 0.0000
100 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
101 NEUTROPENIA 4 0.0000
102 BURNING SENSATION 2 0.0000
103 HYPERKALAEMIA 1 0.0000
104 HEPATIC FUNCTION ABNORMAL 1 0.0000
105 PARAESTHESIA 4 0.0000
106 CARDIO-RESPIRATORY ARREST 1 0.0000
107 PULMONARY OEDEMA 1 0.0000
108 SKIN DISCOLOURATION 1 0.0000
109 CARDIAC DISORDER 2 0.0000
110 OCULAR HYPERAEMIA 1 0.0000
111 PULMONARY EMBOLISM 2 0.0000
112 LEUKOPENIA 1 0.0000
113 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
114 PLATELET COUNT DECREASED 2 0.0000
115 ANAPHYLACTIC REACTION 1 0.0000
116 THROMBOCYTOPENIA 2 0.0000
117 STOMATITIS 1 0.0000
118 PRODUCT USE ISSUE 3 0.0000
119 DEEP VEIN THROMBOSIS 1 0.0000
120 HEPATIC ENZYME INCREASED 1 0.0000
121 HOT FLUSH 1 0.0000
122 DECREASED APPETITE 3 0.0000
123 CARDIAC FAILURE 1 0.0000
124 TREMOR 2 0.0000
125 URTICARIA 2 0.0000
126 RENAL IMPAIRMENT 1 0.0000
127 PYREXIA 4 0.0000
128 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
129 MUSCULOSKELETAL STIFFNESS 1 0.0000
130 NO ADVERSE EVENT 2 0.0000
131 MUSCLE SPASMS 2 0.0000
132 BREAST CANCER 1 0.0000
133 NEUROPATHY PERIPHERAL 1 0.0000
134 ATRIAL FIBRILLATION 1 0.0000
135 DYSPEPSIA 1 0.0000
136 HEART RATE INCREASED 1 0.0000
137 SINUSITIS 1 0.0000
138 HAEMOGLOBIN DECREASED 1 0.0000
139 ERYTHEMA 2 0.0000
140 PNEUMONIA 3 0.0000
141 INFLUENZA 1 0.0000
142 SEPSIS 1 0.0000
143 DYSPNOEA 5 0.0000
144 MUSCULAR WEAKNESS 1 0.0000
145 OEDEMA PERIPHERAL 1 0.0000
146 OFF LABEL USE 7 0.0000
147 LOSS OF CONSCIOUSNESS 1 0.0000
148 HYPERHIDROSIS 1 0.0000
149 INSOMNIA 2 0.0000
150 DRY SKIN 1 0.0000
151 INFECTION 1 0.0000
152 MALAISE 3 0.0000
153 BLOOD PRESSURE INCREASED 1 0.0000
154 ACUTE KIDNEY INJURY 1 0.0000
155 URINARY TRACT INFECTION 1 0.0000
156 HYPERSENSITIVITY 1 0.0000
157 ANAEMIA 1 0.0000
158 GAIT DISTURBANCE 1 0.0000
159 SOMNOLENCE 1 0.0000
160 CONSTIPATION 1 0.0000
161 BACK PAIN 1 0.0000
162 ABDOMINAL PAIN 1 0.0000
163 VOMITING 2 0.0000
164 FATIGUE 3 0.0000
165 COUGH 1 0.0000
166 PAIN 2 0.0000
167 ASTHENIA 1 0.0000
168 NAUSEA 2 0.0000
169 ARTHRALGIA 1 0.0000
170 RASH 1 0.0000
171 DIZZINESS 1 0.0000
172 DIARRHOEA 1 0.0000
173 DEATH 1 0.0000